Suppr超能文献

非酒精性脂肪性肝病中CYP2E1的诱导

Induction of CYP2E1 in non-alcoholic fatty liver diseases.

作者信息

Aljomah Ghanim, Baker Susan S, Liu Wensheng, Kozielski Rafal, Oluwole Janet, Lupu Benita, Baker Robert D, Zhu Lixin

机构信息

Digestive Diseases and Nutrition Center, Women and Children's Hospital of Buffalo, Department of Pediatrics, SUNY at Buffalo, United States.

Digestive Diseases and Nutrition Center, Women and Children's Hospital of Buffalo, Department of Pediatrics, SUNY at Buffalo, United States.

出版信息

Exp Mol Pathol. 2015 Dec;99(3):677-81. doi: 10.1016/j.yexmp.2015.11.008. Epub 2015 Nov 10.

Abstract

Mounting evidence supports a contribution of endogenous alcohol metabolism in the pathogenesis of non-alcoholic steatohepatitis (NASH). However, it is not known whether the expression of alcohol metabolism genes is altered in the livers of simple steatosis. There is also a current debate on whether fatty acids induce CYP2E1 in fatty livers. In this study, expression of alcohol metabolizing genes in the liver biopsies of simple steatosis patients was examined by quantitative real-time PCR (qRT-PCR), in comparison to biopsies of NASH livers and normal controls. Induction of alcohol metabolizing genes was also examined in cultured HepG2 cells treated with ethanol or oleic acid, by qRT-PCR and Western blots. We found that the mRNA expression of alcohol metabolizing genes including ADH1C, ADH4, ADH6, catalase and CYP2E1 was elevated in the livers of simple steatosis, to similar levels found in NASH livers. In cultured HepG2 cells, ethanol induced the expression of CYP2E1 mRNA and protein, but not ADH4 or ADH6; oleic acid did not induce any of these genes. These results suggest that elevated alcohol metabolism may contribute to the pathogenesis of NAFLD at the stage of simple steatosis as well as more severe stages. Our in vitro data support that CYP2E1 is induced by endogenous alcohol but not by fatty acids.

摘要

越来越多的证据支持内源性酒精代谢在非酒精性脂肪性肝炎(NASH)发病机制中的作用。然而,尚不清楚酒精代谢基因的表达在单纯性脂肪变性肝脏中是否发生改变。目前也存在关于脂肪酸是否在脂肪肝中诱导CYP2E1的争论。在本研究中,通过定量实时PCR(qRT-PCR)检测了单纯性脂肪变性患者肝活检组织中酒精代谢基因的表达,并与NASH肝脏活检组织和正常对照进行比较。还通过qRT-PCR和蛋白质印迹法检测了用乙醇或油酸处理的培养HepG2细胞中酒精代谢基因的诱导情况。我们发现,包括ADH1C、ADH4、ADH6、过氧化氢酶和CYP2E1在内的酒精代谢基因的mRNA表达在单纯性脂肪变性肝脏中升高,达到NASH肝脏中的相似水平。在培养的HepG2细胞中,乙醇诱导CYP2E1 mRNA和蛋白质的表达,但不诱导ADH4或ADH6;油酸不诱导这些基因中的任何一个。这些结果表明,酒精代谢增加可能在单纯性脂肪变性阶段以及更严重阶段对非酒精性脂肪性肝病(NAFLD)的发病机制起作用。我们的体外数据支持CYP2E1是由内源性酒精而非脂肪酸诱导的。

相似文献

1
Induction of CYP2E1 in non-alcoholic fatty liver diseases.
Exp Mol Pathol. 2015 Dec;99(3):677-81. doi: 10.1016/j.yexmp.2015.11.008. Epub 2015 Nov 10.
2
Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
Exp Mol Pathol. 2017 Feb;102(1):162-180. doi: 10.1016/j.yexmp.2017.01.003. Epub 2017 Jan 7.
5
The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role.
Drug Metab Rev. 2004 Oct;36(3-4):511-29. doi: 10.1081/dmr-200033441.
6
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.
Hepatology. 1998 Jan;27(1):128-33. doi: 10.1002/hep.510270121.
10
Relevance of CYP2E1 to non-alcoholic fatty liver disease.
Subcell Biochem. 2013;67:165-75. doi: 10.1007/978-94-007-5881-0_5.

引用本文的文献

4
Impact of microplastics on the human digestive system: From basic to clinical.
World J Gastroenterol. 2025 Jan 28;31(4):100470. doi: 10.3748/wjg.v31.i4.100470.
5
A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver.
Cell Rep Med. 2024 Dec 17;5(12):101871. doi: 10.1016/j.xcrm.2024.101871. Epub 2024 Dec 9.
6
Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review.
Arch Toxicol. 2025 Jan;99(1):1-22. doi: 10.1007/s00204-024-03889-x. Epub 2024 Oct 23.
7
Albumin infusion ameliorates liver injury in streptozotocin-induced diabetic rats.
Vet Med (Praha). 2022 Mar 6;67(5):245-256. doi: 10.17221/14/2021-VETMED. eCollection 2022 May.
10
The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease.
Antioxidants (Basel). 2023 Apr 10;12(4):903. doi: 10.3390/antiox12040903.

本文引用的文献

1
Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers.
J Pathol. 2016 Mar;238(4):531-42. doi: 10.1002/path.4650. Epub 2016 Jan 29.
2
Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease.
FEMS Microbiol Ecol. 2015 Feb;91(2):1-9. doi: 10.1093/femsec/fiu002. Epub 2014 Dec 5.
7
Nonalcoholic fatty liver disease as a comorbidity of childhood obesity.
Ped Health. 2009 Jun 1;3(3):271-281. doi: 10.2217/phe.09.21.
8
Role of alcohol metabolism in non-alcoholic steatohepatitis.
PLoS One. 2010 Mar 8;5(3):e9570. doi: 10.1371/journal.pone.0009570.
9
Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome.
Cleve Clin J Med. 2008 Oct;75(10):721-8. doi: 10.3949/ccjm.75.10.721.
10
Effects of steatosis on drug-metabolizing capability of primary human hepatocytes.
Toxicol In Vitro. 2007 Mar;21(2):271-6. doi: 10.1016/j.tiv.2006.07.008. Epub 2006 Jul 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验